Gurney Austin 4
4 · OncoMed Pharmaceuticals Inc · Filed Dec 26, 2018
Insider Transaction Report
Form 4
Gurney Austin
See Remarks
Transactions
- Sale
Common Stock
2018-12-24$0.60/sh−11,117$6,669→ 66,807 total
Footnotes (2)
- [F1]Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit ("RSU") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.5601 to $0.6, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.